We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
137 hedge funds and large institutions have $1.43B invested in Madrigal Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
137% more call options, than puts
Call options by funds: $8.08M | Put options by funds: $3.41M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
43% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 37
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
4% more funds holding
Funds holding: 132 → 137 (+5)
5% more capital invested
Capital invested by funds: $1.36B → $1.43B (+$63.1M)
3.16% less ownership
Funds ownership: 79.34% → 76.17% (-3.2%)
Holders
137
Holders Change
+5
Holders Change %
+3.79%
% of All Funds
2.41%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
21
Increased
53
Reduced
37
Closed
16
Calls
$8.08M
Puts
$3.41M
Net Calls
+$4.66M
Net Calls Change
-$225K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$24.8M |
| 2 |
Morgan Stanley
New York
|
+$24.6M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$23.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.2M |
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$100M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$37.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.99M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.72M |
